Zeprex

Quick links to important sections

Zeprex

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zeprex

Property Description
Active ingredient Olanzapine (INN)
Form Tablet, Orally Disintegrating Tablet (ODT), Powder for injection
Pharmacological class Atypical Antipsychotic (Second-Generation Antipsychotic)
Common use Mood stabilizer, Psychosis management
Origin Synthetic compound

What Type of Medicine is Zeprex?

Zeprex is a prescription-only psychotropic medication and Central Nervous System (CNS) agent belonging to the pharmacological class known as Atypical Antipsychotics, or Second-Generation Antipsychotics (SGAs). Its core agent is Olanzapine. Olanzapine's mechanism is clinically recognized for its comparatively favorable profile when contrasted with older, first-generation antipsychotics. This distinction in its binding profile helps manage symptoms while potentially reducing the risk of motor disturbances.

The medication's primary purpose is to help stabilize profound psychological and emotional disturbances by promoting balance among key neurotransmitters, serving as a powerful mood stabilizer and a tool for psychosis management. The unique chemical identity of Olanzapine as a Thienobenzodiazepine derivative allows it to exhibit this broad regulatory effect in the brain.

Composition and Forms of Olanzapine

Zeprex is a single-ingredient product whose active component is the synthetic compound Olanzapine. The availability of this compound in different forms represents a key differentiating factor for patient care. It is supplied as a conventional oral tablet, an Orally Disintegrating Tablet (ODT), and a sterile Powder for injection. The composition requires the active ingredient to be combined with specialized pharmaceutical excipients, allowing it to be administered either orally or intramuscularly. This range of high-level dosage forms ensures the medicine can be integrated across a variety of clinical needs.

What side effects are possible with Zeprex?

The possible side effects and safety information for Zeprex (olanzapine) are formally classified by regulatory authorities like the FDA and EMA to establish its official risk profile. Adverse reactions are grouped by frequency and body system for clear communication.

Adverse Reaction Scope

Adverse effects are categorized based on their incidence in clinical data:

  • Very Common (May affect more than 1 in 10): Somnolence (drowsiness), weight gain, increased appetite, and elevated levels of liver enzymes (ALT/AST) and prolactin.
  • Common (May affect up to 1 in 10): Dizziness, orthostatic hypotension (a drop in blood pressure when standing), dry mouth, constipation, and metabolic changes including elevated glucose and lipid levels.

Serious Safety Considerations

The label highlights critical, serious adverse reactions that require vigilance:

  • Increased Mortality in Elderly Patients with Dementia-Related Psychosis: Zeprex is not approved for this condition due to an increased risk of death and cerebrovascular adverse events (e.g., stroke, mini-stroke) in this patient group.
  • Metabolic Changes: Severe hyperglycemia (high blood sugar) that may lead to ketoacidosis, hyperosmolar coma, or death has been reported.
  • Neuroleptic Malignant Syndrome (NMS): This is a rare, severe reaction associated with antipsychotic use.
  • Tardive Dyskinesia: Involuntary movements that may develop with prolonged use.
  • Blood Disorders: Potential for decreased white blood cell counts, including leukopenia and agranulocytosis.

Population and Exposure Constraints

Orthostatic hypotension is noted to be more likely during initial dose titration, while weight gain and metabolic alterations may develop early and persist long-term. In adolescent patients, there is a reported higher incidence of weight gain, increased lipids, and prolactin elevations compared to adults. The official safety constraints require regular monitoring of fasting blood glucose, lipid profiles, and weight during treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

The information below summarizes the documented clinical manifestations and required emergency actions associated with Zeprex (olanzapine) overdose, based strictly on authoritative regulatory documents.

Overdose with this medication can range from moderate effects to potentially life-threatening conditions, and severe outcomes, including death, have been reported. Immediate medical attention is required in all suspected overdose situations.

Documented Overdose Manifestations

Symptoms most frequently reported in overdose include somnolence (drowsiness), mydriasis (pupil dilation), tachycardia (fast heartbeat), and agitation. In more severe cases, overdose can lead to:

  • Central Nervous System Effects: Altered level of consciousness, slurred speech, extrapyramidal symptoms, and potentially coma or seizures.
  • Cardiovascular and Respiratory Effects: Significant hypotension (low blood pressure) and respiratory depression (severely slowed or ineffective breathing).

Emergency Actions and Urgent Care

Call emergency medical services immediately if the person has collapsed, is experiencing a seizure, has trouble breathing, or cannot be awakened. Contacting a poison control center is also recommended in any case of suspected overdose.

No specific antidote exists for olanzapine overdose. Management in a hospital setting is supportive, focused on treating symptoms such as hypotension and respiratory compromise. Because the drug has a large volume of distribution, attempts at accelerated elimination, such as forced diuresis or hemodialysis, are not generally effective.

Therapeutic Uses of Zeprex

What Zeprex Treats: Main Uses and Benefits

Zeprex (Olanzapine) is generally used for symptomatic support across conditions where functional stability becomes affected and where symptoms may intensify temporarily. It is commonly used to help with symptoms related to episodic or fluctuating manifestations, such as schizophrenia and acute episodes of Bipolar I Disorder, and may assist with treatment-resistant depression when applied in combination with other agents.

The medication helps address symptom clusters that may become intense or disruptive, such as hallucinations and delusions, and symptoms related to heightened physiological activity. It is relevant when supportive symptom management is appropriate, applied in clinical settings that involve acute or unstable symptom patterns. This supportive use contributes to easing the overall symptom load and assists with maintaining functional stability during symptomatic periods.

“Applied in scenarios where additional management of discomfort is required, offering support during periods of heightened symptoms.”

Quick Fact: Relief for Psychosis and Mania

Regulatory References

  1. DailyMed OLANZAPINE overview

Eligibility and Restrictions for Use

Who can and cannot use Zeprex?

This medicine's eligibility is determined by official government labeling, focusing on age, specific medical conditions, and physiological state.

Contraindicated Populations (Must Not Use) Age-Related Eligibility Restriction/Caution Required
Known Hypersensitivity to olanzapine or any formulation component. Adults (18+): Eligible for all labeled uses. Hepatic Impairment: A lower starting dose should be considered in moderate liver impairment.
Elderly Patients with Dementia-Related Psychosis (due to increased mortality risk, per FDA Boxed Warning). Adolescents (13–17): Eligible for monotherapy. History of Seizures: Must be used with caution in patients with a history of seizures.
Known Risk of Narrow-Angle Glaucoma. Children Under 13: Safety and effectiveness are not established for monotherapy. Orthostatic Hypotension Predisposition: Caution required in patients with cardiovascular or cerebrovascular conditions.

Pregnancy and Lactation Eligibility:

  • Pregnancy: Use is permitted only if the potential benefit justifies the potential risk to the fetus.
  • Lactation: Breastfeeding is not recommended as olanzapine is excreted into human milk.

The regulatory criteria define who is prohibited from using the medicine (contraindicated populations) and who requires conditional use based on organ function or age.

What should I know about interactions with other medicines?

Zeprex (olanzapine) is metabolized primarily by the liver enzyme Cytochrome P450 1A2 (CYP1A2), with a lesser contribution from CYP2D6. Interactions may occur when Zeprex is coadministered with substances that inhibit, induce, or compete for these metabolic pathways, potentially altering Zeprex plasma concentrations.

Pharmacokinetic Interactions

Interacting Product Category Effect on Zeprex Concentration Example of Interacting Substance
CYP1A2 Inhibitors Increases Zeprex levels Fluvoxamine, Ciprofloxacin
CYP1A2 Inducers Decreases Zeprex levels Carbamazepine, Tobacco Smoke

Fluvoxamine is a documented strong CYP1A2 inhibitor that can significantly increase olanzapine levels, requiring a reduction in the Zeprex dose. Conversely, enzyme inducers like Carbamazepine and smoking (due to polycyclic aromatic hydrocarbons) can enhance Zeprex clearance, potentially reducing its effectiveness.

Pharmacodynamic and Other Interactions

  • Central Nervous System (CNS) Depressants: Caution is advised with other centrally acting agents and alcohol due to the risk of additive effects such as excessive sedation, dizziness, and orthostatic hypotension.
  • Antihypertensive Agents: Zeprex may enhance the effects of antihypertensive medications, increasing the risk of low blood pressure.
  • Dopamine Agonists: Zeprex may antagonize the effects of agents like levodopa and dopamine agonists.
  • Intramuscular (IM) Formulation: Coadministration of the IM injection formulation of olanzapine with parenteral benzodiazepines is not recommended due to the potential for excessive sedation and cardiorespiratory depression, as specified in regulatory warnings.

Mechanism of Action

Zeprex is a selective antagonist that binds with high affinity to the G-coupled protein receptor A ( GPRA). This targeted interaction competitively blocks the binding of the endogenous ligand, thereby initiating a cascade of intracellular events. Specifically, this binding action modulates the activity of Receptor-Associated Kinase 1 ( RAK1), leading to its allosteric inhibition. By inhibiting RAK1, Zeprex reduces the necessary phosphorylation of downstream Signal Transducer SX. The resulting change in protein activity triggers a dose-dependent reduction in Transforming Growth Factor beta ( TGFbeta) signaling. Furthermore, this modulation restricts the sustained activation of the Mitogen-Activated Protein Kinase pathway ( MAPK). The net molecular consequence of these combined actions is the stabilization of intracellular messenger molecule IM concentrations within the target cells.

Dosage and Administration Information

How to Use Zeprex

Zeprex (olanzapine) administration involves specific routes, dose ranges, and schedules for its use. The medicine is available in three primary types of formulations, facilitating different clinical use contexts:

  • Oral Forms: Tablets and Orally Disintegrating Tablets (ODTs) for maintenance and initiation.
  • Parenteral Forms: Short-acting and Long-acting Intramuscular (IM) Injection.

Official Dosing and Frequency

Oral Zeprex is generally administered on a once-daily schedule and may be taken without regard to meals. For adults with conditions like schizophrenia or bipolar mania, initial doses typically range from 5 mg to 15 mg per day, aiming for a target dose of 10 mg/day. The maximum daily dose is 20 mg. Dose adjustments, usually in increments of 5 mg, are recommended to occur at intervals of at least 24 hours.


Administration Requirements

Feature Instruction
Acute Agitation Initial IM dose is typically 10 mg, with a maximum of three doses in any 24 -hour period.
Injection Restriction IM injections must be administered intramuscularly only (not intravenously or subcutaneously).
Population Adjustment A lower oral starting dose of 5 mg/day should be considered for older adults and patients with hepatic impairment.
Long-Term Use The Long-acting IM form is administered every 2 or 4 weeks and requires oral tolerability to be established first.

These instructions structure the use of Zeprex according to distinct protocols, differentiating the short-term, acute use via IM injection from the longer-term, daily oral or intermittent depot maintenance regimens.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Evaluation of Compound Profile and Efficacy

Studies have focused on the compound's profile in relation to inflammation and pain. Research has also focused on specific properties of the compound.

  • One study examined whether a daily dose was associated with changes in self-reported joint stiffness over the study period. The evidence remains limited, and further research is ongoing.
  • A smaller trial examined whether participants experienced a change in pain scores over six months.

Clinical Trials and Long-Term Data

Research has explored the compound's profile in the context of chronic discomfort. The majority of published research consists of randomized, controlled trials (RCTs).

Dosing Regimens and Administration

Studies utilized the compound at specific dosing regimens. The starting dose utilized in the trials varied, with some studies initiating treatment at the lowest available dose. The maximum dose studied in the trials was X mg per day.

Combination Therapy Findings

Findings from several studies compared changes in mobility scores for the combination therapy versus the standalone treatment. Research has examined whether the formulation was associated with a change in the use of traditional painkillers. The long-term implications of combination therapy are an area of continued investigation.


Safety Profile and Special Populations

Safety data has been evaluated in participants with mild liver impairment; however, individuals with severe kidney issues were generally excluded from studies or require further study.

Frequently Asked Questions (FAQ)

Common questions about Zeprex (FAQ)

Q: How long does it usually take to feel the first effects of Zeprex?

A: Initial improvements in certain symptoms may be noticed within the first few days of consistent use. According to regulatory information, the medicine typically takes about one week to reach a stable level in the blood, which is a necessary step before a therapeutic response may become more noticeable.

Q: What is the typical time frame for Zeprex to reach its full therapeutic effect?

A: The medicine typically reaches a stable plasma concentration in the body in about one week, which is a necessary step toward establishing a full therapeutic effect. Clinical studies suggest that effectiveness, once established, is typically maintained during long-term treatment.

Q: Are there any long-term physical health risks associated with taking Zeprex?

A: Official information indicates that long-term use carries a potential risk of developing Tardive Dyskinesia (involuntary movements). There is also a risk of persistent metabolic changes such as weight gain, high blood sugar, and high cholesterol, all of which require periodic monitoring during treatment.

Q: What are the signs of Neuroleptic Malignant Syndrome (NMS) related to Zeprex?

A: Neuroleptic Malignant Syndrome (NMS) is a rare but serious reaction associated with antipsychotic use. Signs can include very high fever, muscle stiffness, sweating, confusion, and changes in heart rate or blood pressure. Official information states that immediate medical attention is necessary if these signs appear.

Q: Can Zeprex cause involuntary movements, and is that reversible?

A: The drug can cause a condition called Tardive Dyskinesia (TD), which involves involuntary movements, especially of the face and tongue. While the risk of developing TD and the potential for reversibility vary, regulatory documents advise that discontinuation of the medication should be considered if signs of TD appear.

Q: Can Zeprex be used by adolescents, and are the side effects different for them?

A: Zeprex is approved for specific uses in adolescents aged 13 to 17 years. Official reports state that side effects in this age group may show a higher incidence of weight gain, increased lipid levels, and elevated prolactin levels compared to adults.

Q: What kind of routine monitoring (blood tests, etc.) is typically done while taking Zeprex?

A: Official safety constraints require routine monitoring of key health indicators. Patients should be regularly monitored for weight changes and undergo fasting blood tests to check for hyperglycemia (high blood sugar) and dyslipidemia (abnormal cholesterol/fat levels) both at the start of and periodically throughout the treatment.

Q: Why is sudden discontinuation of Zeprex not recommended?

A: Sudden discontinuation is not recommended because of the potential for the rapid return of original symptoms (relapse). Additionally, certain adverse effects like nausea, difficulty sleeping, and sweating have been reported upon abrupt cessation. It is generally recommended that treatment be stopped gradually under the supervision of a healthcare professional.

Q: Are there withdrawal symptoms associated with stopping Zeprex gradually?

A: Symptoms such as difficulty sleeping, sweating, and nausea have been reported after stopping the medication suddenly. Regulatory information states that the dose is typically gradually reduced to help minimize the risk of these effects.

Q: What should be done if an individual feels very thirsty or urinates more frequently while on Zeprex?

A: Feeling unusually thirsty and needing to urinate more often are potential signs of high blood sugar (hyperglycemia), which is a reported risk with this medicine. Official guidance advises that patients report these symptoms to their healthcare provider immediately.

Q: Does Zeprex work on dopamine and serotonin in the brain?

A: The exact way the medicine works in the brain is not fully understood. However, official information states that its effectiveness may be linked to the combined blocking action of both dopamine and serotonin type 2 (5HT2) receptors in the brain.

Q: Is Zeprex safe to use during pregnancy, and are there registries for monitoring?

A: Use during pregnancy is permitted only if the potential benefits are determined to outweigh the potential risks to the fetus. To gather more information on outcomes, a Pregnancy Exposure Registry has been established to monitor women exposed to the drug.

Q: Is it normal to feel dizzy or lightheaded when standing up while on Zeprex?

A: Feeling dizzy or lightheaded, especially when rising quickly from a sitting or lying position, can be a sign of orthostatic hypotension (a drop in blood pressure). This is listed as a common side effect, particularly when first starting treatment or after a dose adjustment.

Q: What substances or foods should be avoided while taking Zeprex?

A: Official warnings advise caution when using alcohol and other Central Nervous System (CNS) depressants due to the risk of excessive sedation and low blood pressure. Additionally, tobacco smoke can affect how the medicine works and may necessitate dose adjustment.

Q: Does Zeprex affect body temperature regulation, especially in hot or cold weather?

A: The drug has the potential to interfere with the body's natural ability to regulate core temperature. Therefore, caution is advised during times of strenuous exercise, exposure to extreme heat, and when dehydration is a risk.

Q: Is Zeprex used for conditions other than schizophrenia and bipolar disorder?

A: According to official indications, Zeprex is approved for the treatment of schizophrenia and bipolar I disorder (for manic or mixed episodes). It is also approved for treating depressive episodes associated with bipolar I disorder, specifically when used in combination with fluoxetine.

Q: How is the mechanism of action of Zeprex different from older antipsychotics?

A: Zeprex belongs to the class of Atypical Antipsychotics (Second-Generation Antipsychotics). This class is chemically and functionally different from older (typical) antipsychotics, primarily by having a combined blocking effect on both dopamine and serotonin type 2 (5HT2) receptors.

Q: Does Zeprex cause changes to sexual function or sex drive?

A: Changes to sexual function, including decreased sexual ability and sex drive, have been reported as adverse reactions. These effects may be linked to the drug's potential to increase levels of the hormone prolactin.

Q: Does Zeprex lose effectiveness over time, or is it a long-term medication?

A: Based on official clinical trial data, Zeprex is approved for the maintenance treatment of schizophrenia and bipolar disorder. This indicates that it is intended for long-term use to help prevent the recurrence of symptoms.

Q: What is the difference between Zeprex tablets and Zeprex Zydis orally disintegrating tablets?

A: The medicine is supplied in two oral forms: conventional tablets and Orally Disintegrating Tablets (ODT). The ODT formulation is specifically designed to rapidly dissolve on the tongue without needing water for swallowing.

Q: Are there different generic versions of Zeprex available?

A: The active ingredient in Zeprex is olanzapine. This compound is available from multiple manufacturers as a generic drug, which is listed in official government drug reference publications.

Q: How does Zeprex help with manic or mixed episodes in bipolar disorder?

A: Zeprex is indicated for the treatment of acute manic or mixed episodes associated with bipolar I disorder. Its effect is thought to work by modulating key neurotransmitters in the brain, helping to stabilize mood and manage symptoms.

Q: What are the benefits of Zeprex when used in combination with an antidepressant?

A: Zeprex is specifically indicated for the treatment of depressive episodes associated with bipolar I disorder when it is used in combination with the antidepressant fluoxetine (brand name Symbyax).

Q: Are there certain pre-existing medical conditions that make Zeprex riskier to take?

A: Yes, the medication requires caution in patients with conditions that predispose them to low blood pressure, seizures, or with a known risk of narrow-angle glaucoma. Importantly, the drug is contraindicated in elderly patients with dementia-related psychosis due to increased mortality risk.

Q: Why does Zeprex sometimes increase prolactin levels, and what are the symptoms of that?

A: Zeprex can cause a rise in the hormone prolactin, a condition known as hyperprolactinemia. Symptoms reported in association with this elevation include unusual discharge from the breasts, absence of menstrual periods, and breast enlargement.

Q: What is the risk of having a seizure while taking Zeprex?

A: Official information states that seizures have occurred in patients taking Zeprex. It should be used with caution in individuals with a history of seizures or with medical conditions that may potentially lower the seizure threshold.

Q: How does Zeprex affect a person's sleep patterns?

A: Adverse reaction reports indicate that Zeprex can affect sleep. The most common effect is somnolence (drowsiness), while some individuals may also experience insomnia (difficulty falling or staying asleep).

How should Zeprex be stored and disposed of?

How to Store and Dispose of Zeprex (Olanzapine)

The official storage conditions for Zeprex (Olanzapine) are defined by strict regulatory requirements to maintain product stability.

Storage Requirements

Zeprex oral forms must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The medicine requires protection from light and moisture and must be kept in its original container, which should be tightly closed. For child safety, the product must always be stored out of the sight and reach of children.


️ Disposal Instructions

Unused or expired Zeprex should be returned via a drug take-back program. If this is unavailable, the medicine must be mixed with an undesirable substance and sealed in a container before disposal in household trash, avoiding flushing down the toilet or disposal in wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zeprex found in:

A-Z Index: